Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
SBTX

SBTX - Silverback Therapeutics, Inc. Stock Price, Fair Value and News

$10.50+0.50 (+5.00%)
Market Closed

40/100

SBTX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

40/100

SBTX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

SBTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SBTX Price Action

Last 7 days

-16%

Last 30 days

-46.8%

Last 90 days

-22.2%

Trailing 12 Months

-57.1%

SBTX RSI Chart

SBTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

SBTX Valuation

Market Cap

1.0B

Price/Earnings (Trailing)

-6.08

Price/Sales (Trailing)

12.37

EV/EBITDA

-6.46

Price/Free Cashflow

-6.09

SBTX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

SBTX Fundamentals

SBTX Revenue

Revenue (TTM)

84.3M

Rev. Growth (Yr)

-67.56%

Rev. Growth (Qtr)

-13.58%

SBTX Earnings

Earnings (TTM)

-171.4M

Earnings Growth (Yr)

-182.33%

Earnings Growth (Qtr)

19.47%

SBTX Profitability

EBT Margin

-203.35%

Return on Equity

-150.04%

Return on Assets

-52.32%

Free Cashflow Yield

-16.42%

SBTX Investor Care

Shares Dilution (1Y)

1.71%

Diluted EPS (TTM)

-1.74

SBTX Alerts

  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202597.1M112.3M142.8M84.3M
2024059.9M74.5M89.1M
202316.0M30.6M45.2M0
20224.5M3.4M2.4M1.3M
20210005.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About Silverback Therapeutics, Inc.

SBTX
0
 WEBSITEsilverbacktx.com

Silverback Therapeutics, Inc. Frequently Asked Questions

SBTX is the stock ticker symbol of Silverback Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Silverback Therapeutics, Inc. is 1.04 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, SBTX's PE ratio (Price to Earnings) is -6.08 and Price to Sales (PS) ratio is 12.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SBTX PE ratio will change depending on the future growth rate expectations of investors.